The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

Marijke Coomans*, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin van den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstrom, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Martin J. B. TaphoornEORTC Quality Life Grp, EORTC Brain Tumor Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)190-198
Number of pages9
JournalEuropean Journal of Cancer
Volume116
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Glioma
  • Health-related quality of life (HRQoL)
  • Prognostic factor
  • Brain tumour
  • Survival
  • PHASE-III
  • PREDICTING SURVIVAL
  • CANCER-PATIENTS
  • COGNITIVE FUNCTION
  • CLINICAL-TRIALS
  • BRAIN-TUMOR
  • EORTC
  • GLIOBLASTOMA
  • VALIDATION
  • SYMPTOMS

Cite this

Coomans, M., Dirven, L., Aaronson, N. K., Baumert, B. G., van den Bent, M., Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmstrom, A., Martinelli, F., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., ... EORTC Brain Tumor Grp (2019). The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. European Journal of Cancer, 116, 190-198. https://doi.org/10.1016/j.ejca.2019.05.012